Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study
- PMID: 28451806
- PMCID: PMC5557016
- DOI: 10.1007/s10552-017-0896-9
Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study
Abstract
Purpose: African American men have the highest incidence of prostate cancer among ethnic groups, and racial disparity is highest in younger men. Prostate cancer prevalence is rising in HIV-infected men due to improved survival on antiretroviral therapies, yet little is known about racial differences in prostate cancer risk by HIV-infection status and age.
Methods: This is a prospective cohort study of prostate cancer risk in 2,800 HIV-infected and -uninfected men who have sex with men (MSM) aged 40-70 years (22% African American) who were enrolled in the multicenter AIDS cohort study from 1996 to 2010. Poisson regression models were used to examine associations between race and HIV-infection status and prostate cancer risk among men aged 40-70, 40-55, and 56-70 years.
Results: Among men aged 40-70 years, incidence rates (IR) per 100,000 person-years were 169 among all men and 276 among African American HIV-infected men. Prostate cancer risk was similar by HIV-infection status (IRR 1.0, 95% CI 0.55-1.82), but nearly threefold higher in African Americans compared to non-African Americans in adjusted models (IRRs 2.66 and 3.22, 95% CIs 1.36-5.18 and 1.27-8.16 for all or HIV-infected men, respectively). Racial disparity in prostate cancer risk was greatest in African American men aged 40-55 years (adjusted IRR 3.31, 95% CI 1.19-9.22). Prostate cancer risk showed associations with family history of prostate cancer (p = 0.001), but not heavy smoking, androgen supplement use, or HIV-related factors.
Conclusions: Among MSM, African American HIV-positive and HIV-negative men aged 40-55 years have threefold increased risk of young-onset prostate cancer compared to non-African American men, highlighting the need to make informed decisions about screening in this population.
Keywords: Cancer epidemiology; Cancer racial disparity; Cancer risk; HIV-1; Prostate cancer.
Conflict of interest statement
References
-
- Schymura MJ, Sun L, Percy-Laurry A. Prostate cancer collaborative stage data items–their definitions, quality, usage, and clinical implications: a review of SEER data for 2004–2010. Cancer. 2014;120(Suppl 23):3758–70. - PubMed
MeSH terms
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- HHSN261201000140C/CA/NCI NIH HHS/United States
- T32 AI007386/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- U58 DP000795/DP/NCCDPHP CDC HHS/United States
- DP1 DA028994/DA/NIDA NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- U58 DP003862/DP/NCCDPHP CDC HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- UL1 TR001102/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
